Apretude

Apretude is an injectable medication containing cabotegravir, used for HIV prevention. This long-acting treatment is administered intramuscularly and is manufactured by Viiv Healthcare B.V.

Apretude is primarily used for pre-exposure prophylaxis (PrEP) in HIV prevention. It is designed for individuals at risk of HIV infection, providing a long-lasting alternative to daily oral medications. The primary keyword here is 'HIV prevention,' and related searches might include 'what is Apretude used for' or 'cabotegravir for HIV.'

Apretude works by maintaining high levels of cabotegravir in the body, which helps prevent HIV infection. Common effects may include injection site reactions, such as pain or swelling. Some individuals might experience fatigue or headaches, but these are generally mild and temporary.

Apretude should be administered by a healthcare professional to ensure proper intramuscular injection. It is important to discuss any allergies or medical conditions with your healthcare provider before starting this treatment. Regular monitoring may be required to assess its effectiveness and safety.

Apretude may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with your healthcare provider, as it may affect the overall treatment plan.